Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 215,157 | 215,236 | 591,906 | 276,402 | 273,732 |
| Marketable Securities | 62,441 | 81,691 | 71,194 | 32,694 | N/A |
| Receivables | 248,298 | 271,155 | 241,092 | 259,327 | 256,270 |
| Inventories | 436,930 | 421,775 | 403,422 | 389,608 | 366,251 |
| Other current assets | 50,370 | 28,790 | 35,369 | 32,643 | 0 |
| TOTAL | $1,099,522 | $1,112,286 | $1,415,650 | $1,058,036 | $1,027,229 |
| Non-Current Assets | |||||
| PPE Net | 390,906 | 373,570 | 345,356 | 340,199 | 318,718 |
| Intangibles | 2,326,083 | 2,324,582 | 2,062,844 | 2,123,295 | 2,103,169 |
| Other Non-Current Assets | 249,292 | 264,057 | 254,374 | 260,458 | 290,255 |
| TOTAL | $2,966,281 | $2,962,209 | $2,662,574 | $2,723,952 | $2,712,142 |
| Total Assets | $4,065,803 | $4,074,495 | $4,078,224 | $3,781,988 | $3,739,371 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 572,442 | N/A | N/A | N/A | 75,700 |
| Accounts payable and accrued liabilities | 77,666 | 107,492 | 94,397 | 92,326 | 93,550 |
| Accrued Expenses | 208,363 | 172,087 | 164,478 | 176,299 | 154,175 |
| Other current liabilities | 9,990 | 9,905 | 7,841 | 8,540 | 8,139 |
| TOTAL | $912,563 | $328,316 | $302,394 | $306,980 | $355,712 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,205,092 | 1,229,365 | 1,265,636 | 914,763 | 850,089 |
| Other Non-Current Liabilities | 357,616 | 896,094 | 880,811 | 937,044 | 879,896 |
| TOTAL | $1,631,653 | $2,211,984 | $2,177,878 | $1,887,124 | $1,804,438 |
| Total Liabilities | $2,544,216 | $2,540,300 | $2,480,272 | $2,194,104 | $2,160,150 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,164 | 77,582 | 78,800 | 78,220 | 78,176 |
| Common Shares | 916 | 916 | 915 | 909 | 909 |
| Retained earnings | 920,481 | 931,176 | 943,578 | 946,859 | 927,025 |
| Other shareholders' equity | -24,664 | -18,479 | -11,068 | -15,368 | 1,968 |
| TOTAL | $1,521,587 | $1,534,195 | $1,597,952 | $1,587,884 | $1,579,221 |
| Total Liabilities And Equity | $4,065,803 | $4,074,495 | $4,078,224 | $3,781,988 | $3,739,371 |